These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19700325)

  • 1. mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).
    Shao L; Wang F; Hewitt MC; Barberich TJ
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5679-83. PubMed ID: 19700325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-induced respiratory depression: are 5-HT4a receptor agonists the cure?
    Eilers H; Schumacher MA
    Mol Interv; 2004 Aug; 4(4):197-9. PubMed ID: 15304555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of opioid and gene variants].
    Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N
    Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural comparisons of meptazinol with opioid analgesics.
    Li W; Hao JL; Tang Y; Chen Y; Qiu ZB
    Acta Pharmacol Sin; 2005 Mar; 26(3):334-8. PubMed ID: 15715930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicine. A sigh of relief for painkillers.
    Couzin J
    Science; 2003 Jul; 301(5630):150. PubMed ID: 12855777
    [No Abstract]   [Full Text] [Related]  

  • 6. Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?
    Madariaga-Mazón A; Marmolejo-Valencia AF; Li Y; Toll L; Houghten RA; Martinez-Mayorga K
    Drug Discov Today; 2017 Nov; 22(11):1719-1729. PubMed ID: 28743488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR study of 4-phenylpiperidine derivatives as mu opioid agonists by neural network method.
    Wang XH; Tang Y; Xie Q; Qiu ZB
    Eur J Med Chem; 2006 Feb; 41(2):226-32. PubMed ID: 16403590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
    Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
    Chem Biol Drug Des; 2009 Oct; 74(4):335-42. PubMed ID: 19691470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.
    Shao L; Hewitt M; Jerussi TP; Wu F; Malcolm S; Grover P; Fang K; Koch P; Senanayake C; Bhongle N; Ribe S; Bakale R; Currie M
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1674-80. PubMed ID: 18242987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double decarboxylation reaction of an oxazolidinone and carboxylic Acid: its application to the synthesis of a new opioid lead compound.
    Fujii H; Imaide S; Watanabe A; Yoza K; Nakajima M; Nakao K; Mochizuki H; Sato N; Nemoto T; Nagase H
    J Org Chem; 2010 Feb; 75(3):995-8. PubMed ID: 20070096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labelling studies for structure elucidation of a new hydroxymetabolite of tramadol.
    Potyka U; Paar WD; Sauerbruch T; von Unruh GE
    Isotopes Environ Health Stud; 1998; 34(1-2):119-25. PubMed ID: 9854846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing safer analgesics: a focus on μ-opioid receptor pathways.
    Pergolizzi JV; LeQuang JA; Taylor R; Ossipov MH; Colucci D; Raffa RB
    Expert Opin Drug Discov; 2018 Oct; 13(10):965-972. PubMed ID: 30175624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT4 receptor agonists: similar but not the same.
    De Maeyer JH; Lefebvre RA; Schuurkes JA
    Neurogastroenterol Motil; 2008 Feb; 20(2):99-112. PubMed ID: 18199093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of interaction between metoclopramide and morphine in vitro and in mice.
    Ung D; Cowan A; Parkman HP; Nagar S
    Xenobiotica; 2008 Nov; 38(11):1365-76. PubMed ID: 18942041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased colonic transit in rats produced by a combination of a cholinesterase inhibitor with a 5-HT4 receptor agonist.
    Campbell-Dittmeyer K; Hicks GA; Earnest DL; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2009 Nov; 21(11):1197-e108. PubMed ID: 19210632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Cisapride, Buprenorphine, and Their Combination on Gastrointestinal Transit in New Zealand White Rabbits.
    Feldman ER; Singh B; Mishkin NG; Lachenauer ER; Martin-Flores M; Daugherity EK
    J Am Assoc Lab Anim Sci; 2021 Mar; 60(2):221-228. PubMed ID: 33632373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing Safer Analgesics via μ-Opioid Receptor Pathways.
    Chan HCS; McCarthy D; Li J; Palczewski K; Yuan S
    Trends Pharmacol Sci; 2017 Nov; 38(11):1016-1037. PubMed ID: 28935293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
    Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
    Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor reserve reflects differential intrinsic efficacy associated with opioid diastereomers.
    Carliss RD; Keefer JF; Perschke S; Welch S; Rich TC; Weissman AD
    Pharmacol Biochem Behav; 2009 May; 92(3):495-502. PubMed ID: 19463265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options.
    Porreca F; Ossipov MH
    Pain Med; 2009; 10(4):654-62. PubMed ID: 19302436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.